.
.one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
legislation (h 2442) sponsored by braintree rep..
.
more stories from investigations